Lloyd Mitchell Segal

Biotechnology and healthcare leader, advisor and investor.

Montreal, Quebec

Overview 

Lloyd Mitchell Segal is a seasoned biotechnology and healthcare leader with a significant track record in corporate governance and executive roles. Currently serving as the President & Chief Executive Officer of Repare Therapeutics, Segal has held key positions at notable organizations such as Aktis Oncology, MedReleaf, and Valeant Pharmaceuticals, showcasing his expertise in healthcare management and board leadership. His career highlights include serving as the Chairman of the Board of Directors at LMC Diabetes & Endocrinology and leading Persistence Capital Partners as Managing Partner.

Work Experience 

AO

Aktis Oncology

  • Board Member

    2020 - Current

RT

Repare Therapeutics

  • President & Chief Executive Officer

    2016 - 2025

    Repare is a clinical-stage biotechnology company. Our mission is to be the leading precision oncology company delivering Synthetic Lethality/Genome Instability medicines that meaningfully improve the lives of cancer patients.

PP

Pembroke Private Wealth Management

  • Member, Board of Directors, GBC American Fund

    2006 - 2024

VV

Versant Ventures

  • Entrepreneur in Residence

    2016 - 2020

    Versant Ventures is a leading San Francisco-based healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. At Versant my focus was on leading the formation and development of new portfolio companies.

Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.

versantventures.com
M

MedReleaf

  • Chairman Of The Board Of Directors

    2017 - 2018

    MedReleaf (TSX:LEAF) was acquired in July, 2018, by Aurora Cannabis for US$2.5 billion to create the largest global cannabis producer.

LD

LMC Diabetes & Endocrinology

  • Chairman

    2014 - 2018

PC

Persistence Capital Partners

  • Managing Partner

    2010 - 2016

    Private equity fund investing in healthcare.

C

CVCA

  • Member of the Board of Directors

    2014 - 2016

    Canada's Venture Capital and Private Equity National Association

VP

Valeant Pharmaceuticals

  • Member, Board of Directors

    2007 - 2014

Thallion Pharmaceuticals Inc (TLN)

  • Chairman of the Board of Directors

    2010 - 2013

  • Chief Executive Officer

    2007 - 2010

Education 

Articles About Lloyd Mitchell

Relevant Websites